BIOMAT Database Logo BIOMAT Database Logo

Hyperpigmentation as a guiding sign for the diagnosis of visceral leishmaniasis in a patient with human immunodeficiency virus (HIV). 2021

Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
Department of Dermatology, Miguel Servet University Hospital, Zaragoza, Spain.

UI MeSH Term Description Entries
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016773 Leishmaniasis, Cutaneous An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes. Leishmaniasis, American,Leishmaniasis, New World,Leishmaniasis, Old World,Oriental Sore,American Leishmaniasis,Cutaneous Leishmaniases,Cutaneous Leishmaniasis,Leishmaniases, Cutaneous,New World Leishmaniasis,Old World Leishmaniasis,Sore, Oriental
D017495 Hyperpigmentation Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance. Hypermelanosis,Hypermelanoses

Related Publications

Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
Visceral leishmaniasis in a patient with human immunodeficiency virus.
January 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).
July 1989, Annals of internal medicine,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
[Cutaneous leishmaniasis associated with visceral leishmaniasis in a patient infected with human immunodeficiency virus].
October 2009, Medicina clinica,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
[Erythroderma as presentation form of visceral leishmaniasis in a patient with human immunodeficiency virus infection].
November 1992, Revista clinica espanola,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
[Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
May 1989, Medicina clinica,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
Visceral leishmaniasis with cutaneous lesions in a patient infected with human immunodeficiency virus.
July 1998, The British journal of dermatology,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
[Visceral leishmaniasis and peritoneal tuberculosis in a patient with human immunodeficiency virus infection].
September 2003, Medicina clinica,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
Facial hyperpigmentation in a patient with human immunodeficiency virus.
June 2010, Clinical and experimental dermatology,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
Visceral leishmaniasis in human immunodeficiency virus disease.
November 1991, Journal of clinical pathology,
Isabel Abadías-Granado, and Alba Navarro-Bielsa, and Lucía Ferrando-Lamana, and Mª Ángeles Requena-Calleja, and Yolanda Gilaberte
[Visceral leishmaniasis associated with human immunodeficiency virus infection].
January 2001, Enfermedades infecciosas y microbiologia clinica,
Copied contents to your clipboard!